Clinical microbiology laboratories and COVID-19: the calm before the storm
A study published by Clark et al. estimated that 1.7 billion people, comprising 22% of the global population have at least one underlying health condition (i.e., chronic kidney disease, diabetes, cardiovascular disease and chronic respiratory disease) that puts them at an increased risk of severe CO...
Gespeichert in:
Veröffentlicht in: | Future microbiology 2020-10, Vol.15 (15), p.1419-1424 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A study published by Clark et al. estimated that 1.7 billion people, comprising 22% of the global population have at least one underlying health condition (i.e., chronic kidney disease, diabetes, cardiovascular disease and chronic respiratory disease) that puts them at an increased risk of severe COVID-19 infection; an estimated 349 million people are at a high risk for severe COVID-19 infection and would require hospitalization (3). [...]the role of clinical microbiology for the laboratory-based diagnosis of influenza was essentially nil. [...]real time reporting was unavailable during the Spanish flu. [...]in the absence of more dedicated resources, clinical microbiology laboratories may be ill-prepared currently and for the potential increase in cases expected over the coming months. |
---|---|
ISSN: | 1746-0913 1746-0921 |
DOI: | 10.2217/fmb-2020-0216 |